Provider Information

Pharmacy

Point-of-Sale :Prospective Drug Utilization Review (ProDUR)

ProDUR information provided to pharmacists is based on the patients medical diagnosis and prescription history.

The ProDUR program enables the pharmacy provider to screen for drug therapy problems at point-of-sale or distribution. In compliance with OBRA 1990 DUR requirements, pharmacy providers must screen each prescription for certain therapeutic problems using standards consistent with OBRA 1990 requirements.

OBRA requires:

1. A pharmacist using his/her professional judgment shall review the patient record and each prescription drug order presented for dispensing for purposes of promoting therapeutic appropriateness by identifying the following, when possible:

a.
Over or under utilization;

b. Therapeutic duplication;

c. Drug-disease contraindications, where diagnosis is provided by the prescriber;

d. Drug-drug contra-indications;

e. Incorrect drug dosage or duration of drug treatment;

f. Drug allergies; and

g. Clinical abuse/misuse.

2.
Upon recognizing any of the above, the pharmacist shall take appropriate steps to avoid or resolve the problem which shall, if necessary, include consultation with the prescriber.

Point-of-Sale (POS) providers may receive additional ProDUR information provided by the South Dakota POS system. These audits are supplemental to those required by law to be performed by the pharmacy provider and not in lieu of those audits. South Dakota medical assistance ProDUR audits are based on information from the current claim, from claim history for same and different pharmacies, and from the patient’s diagnostic history on medical claims. The medical, clinical, and pharmaceutical information used in POS ProDUR audits is supplied by First Data Bank.

Pharmacists billing via POS can evaluate the ProDUR information and intervene appropriately. ProDUR information is a tool to assist the pharmacist in providing the highest quality of care possible.

Pharmacy Point-of-Sale